Shareholders’ Equity (Tables)

6 Months Ended

Jun. 30, 2025

Shareholders’ Equity [Abstract]

Schedule of Share Option Plan

A summary of the status of options under the Plan as of June 30, 2025 and changes during the relevant period ended on that date is presented below:

	Six months ended June 30, 2025 (unaudited)
	Number of options			Weighted average exercise price		Aggregate intrinsic value		Weighted average remaining contractual life (years)
Outstanding at beginning of period		14,449,650		$	4.62	$	2,964		6.92
Granted		2,304,133		$	2.95
Exercised		-		$	-
Forfeited		(43,952	)	$	5.18
Outstanding at end of period		16,709,831		$	4.38	$	3,687		6.82
Exercisable options		11,103,202		$	4.79	$	2,580		5.91

Schedule of RSUs Under the Plan

A summary of the status of RSUs under the Plan as of June 30, 2025 and changes during the relevant period ended on that date is presented below:

	Six months ended June 30, 2025 (unaudited)
	Unvested RSUs			Weighted- average grant date fair value per share
Outstanding at beginning of period		857,899		$	4.24
Granted		690,106		$	2.81
Vested		(326,306	)	$	4.54
Forfeited		(10,494	)	$	6.52
Outstanding at end of period		1,211,205		$	3.18

Schedule of Total Equity-Based Compensation Expense

The total equity-based compensation expense related to all of the Company’s equity-based awards recognized for the six months ended June 30, 2024 and 2025, was comprised as follows:

	Six months ended June 30,
	2024		2025
	Unaudited
Research and development	$	3,330	$	3,194
Marketing expenses		345		427
General and administrative		1,192		1,710
Total share-based compensation expense	$	4,867	$	5,331